Diagnostic Digest

Increased pathogen detection, reduced hospital length of stay, reduced antibiotic therapies—the BioFire System offers numerous cost saving benefits.

With respiratory pathogens like influenza, RSV, & COVID-19 circulating this winter season, check out these seven ways to protect yourself and family.

What we don't know about COVID-19 still outweighs what we do know, however, COVID-19 isn't the first coronavirus to infect humans. Learn more about coronaviruses.

Epidemiologists work every day to confront a variety of health and safety threats, from influenza to Salmonella infection outbreaks.

Learn the facts about sepsis. 

Dr. Mullis’s groundbreaking invention of polymerase chain reaction (PCR) laid the foundation for BIOFIRE's syndromic testing.

Systematic review and meta-analysis on the impact of molecular rapid diagnostic tests and the role syndromic panels can play in antimicrobial stewardship.

PCR technology is at the heart of our mission here at BioFire. Learn how we use this technology in our syndromic approach to infectious disease diagnostics.

Learn how the BioFire GI Panel provides fast, comprehensive results in about an hour, while helping maximize the stool bench and improve patient care.

This nasty pathogen can cause weeks—or even months—of gastrointestinal distress.

Since many pathogens can manifest with similar symptoms, testing for one pathogen at a time can lead to worsening symptoms, unnecessary antibiotic therapy, and increased length of stay in the hospital.

Join us in celebrating the lab workers who fight on the frontlines of healthcare every day. We know real heroes wear lab coats, goggles, and gloves.